Scopia Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-741,214
| Closed | -$20.2M | – | 20 |
|
|
2020
Q4 | $20.2M | Sell |
741,214
-590,936
| -44% | -$16.1M | 2.56% | 11 |
|
|
2020
Q3 | $24.6M | Sell |
1,332,150
-453,759
| -25% | -$8.38M | 2.91% | 11 |
|
|
2020
Q2 | $36.5M | Buy |
1,785,909
+48,475
| +3% | +$989K | 4.01% | 9 |
|
|
2020
Q1 | $25.3M | Sell |
1,737,434
-274,263
| -14% | -$4M | 2.32% | 13 |
|
|
2019
Q4 | $28.6M | Sell |
2,011,697
-1,208,201
| -38% | -$17.2M | 2.21% | 15 |
|
|
2019
Q3 | $37.3M | Sell |
3,219,898
-664,793
| -17% | -$7.71M | 2.18% | 13 |
|
|
2019
Q2 | $78M | Sell |
3,884,691
-330,281
| -8% | -$6.64M | 3.47% | 12 |
|
|
2019
Q1 | $95.4M | Sell |
4,214,972
-1,695,881
| -29% | -$38.4M | 3.52% | 11 |
|
|
2018
Q4 | $134M | Sell |
5,910,853
-608,572
| -9% | -$13.8M | 4.54% | 8 |
|
|
2018
Q3 | $187M | Hold |
6,519,425
| – | – | 3.6% | 10 |
|
|
2018
Q2 | $178M | Sell |
6,519,425
-139,741
| -2% | -$3.81M | 3.11% | 12 |
|
|
2018
Q1 | $149M | Hold |
6,659,166
| – | – | 2.98% | 16 |
|
|
2017
Q4 | $140M | Hold |
6,659,166
| – | – | 2.52% | 15 |
|
|
2017
Q3 | $166M | Buy |
6,659,166
+686,055
| +11% | +$17.1M | 2.62% | 12 |
|
|
2017
Q2 | $116M | Buy |
5,973,111
+89,455
| +2% | +$1.73M | 2.39% | 17 |
|
|
2017
Q1 | $109M | Buy |
5,883,656
+794,022
| +16% | +$14.7M | 2.01% | 18 |
|
|
2016
Q4 | $96.3M | Buy |
5,089,634
+836,746
| +20% | +$15.8M | 1.83% | 19 |
|
|
2016
Q3 | $95.2M | Buy |
4,252,888
+441,067
| +12% | +$9.87M | 1.68% | 17 |
|
|
2016
Q2 | $67.9M | Buy |
3,811,821
+213,599
| +6% | +$3.8M | 1.4% | 21 |
|
|
2016
Q1 | $49.2M | Buy |
3,598,222
+3,229,087
| +875% | +$44.1M | 0.92% | 23 |
|
|
2015
Q4 | $7.12M | Buy |
+369,135
| New | +$7.12M | 0.14% | 28 |
|